FDMT
4D Molecular Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.97
+1.84%Margins
Gross margin
42.0%
EBITDA margin
-200.9%
EBIT margin
-214.2%
Net margin
-194.7%
FCF margin
-170.3%
-44.0%
Return on equity
-36.4%
Return on assets
-44.1%
Return on invested capital
0.18x
Asset turnover
-$156.1M
Cash from operations
$6.54
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026